NOVO — Januar 2026
-
Is Novo Nordisk (NYSE:NVO) Pricing Reflect Long Term Value After Recent Share Rebound https://finance.yahoo.com/news/novo-nordisk-nyse-nvo-pricing-141117319.html
-
Novo/Norge: Slankemedisin med gigaomsetning https://www.tv2.no/nyheter/slankemedisin-med-gigaomsetning/18455942/
-
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know https://finance.yahoo.com/news/novo-nordisk-nvo-attracting-investor-140004931.html
-
Bloomberg: "Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly" https://www.bloomberg.com/news/videos/2026-01-12/nvidia-to-invest-1b-in-ai-drug-lab-with-eli-lilly-video
-
-
Godt interview med CEO i Jim Cramers show. Han fik lov at komme ud med en masse positivt og gjorde det faktisk rigtig positivt, synes jeg. https://youtu.be/JrpOoIJf1tY
?si=m8Ek8QPAuN0ieevF -
Novo Nordisk ser vægttabspiller tage over en tredjedel af markedet https://proinvestor.com/investornyt/1402366/novo-nordisk-ser-vaegttabspiller-tage-over-en-tredjedel-af-markedet
-
Novo-konkurrent ser vægttabspille lidt senere på markedet https://proinvestor.com/investornyt/1402365/novo-konkurrent-ser-vaegttabspille-lidt-senere-pa-markedet
-
Novo estimerer at 1,5 millioner bruger kopier af vægttabsmedicin https://proinvestor.com/investornyt/1402364/novo-estimerer-at-15-millioner-bruger-kopier-af-vaegttabsmedicin
-
Novo Nordisks anbefaling og kursmål løftes af amerikansk finanshus https://proinvestor.com/investornyt/1402372/novo-nordisks-anbefaling-og-kursmal-loftes-af-amerikansk-finanshus
-
Novo-aktien ligger til kursstigning tirsdag efter stigning i USA mandag https://proinvestor.com/investornyt/1402377/novo-aktien-ligger-til-kursstigning-tirsdag-efter-stigning-i-usa-mandag
-
Potentiel Novo-konkurrent slår på tromme for langtidsvirkende vægttabsmiddel https://proinvestor.com/investornyt/1402376/potentiel-novo-konkurrent-slar-pa-tromme-for-langtidsvirkende-vaegttabsmiddel
-
Pfizer ser enormt potentiale på linje med Viagra i salg af fedmemedicin i håndkøb https://proinvestor.com/investornyt/1402363/pfizer-ser-enormt-potentiale-pa-linje-med-viagra-i-salg-af-fedmemedicin-i-handkob
-
CICC har startet dækning af Novo Nordisk med en «Outperform»-rating og et kursmål på $73,50 for selskabets American Depositary Receipts (ADR).
-
Novos lancering af Wegovy-pillen kan blive en af de største på sit felt spår Danske Bank https://proinvestor.com/investornyt/1402403/novos-lancering-af-wegovy-pillen-kan-blive-en-af-de-storste-pa-sit-felt-spar-danske-bank
-
Zacks upgraded $NVO ’s U.S.-listed shares from “underperform” to “neutral” on Monday and raised its price target by nearly 40% to $65 from $47.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind